Volume 6 – Number 3

Strategies for Overcoming Resistance in HIV-1 Infected Patients Receiving HAART

Prevention of Mother-to-Child Transmission of HIV – Successes, Controversies and Critical Questions

The Epidemiology and Disease Outcomes of Human T-Lymphotropic Virus Type II

How Do Cell-Free HIV Virions Avoid Infecting Dead-End Host Cells and Cell Fragments?

Defensins: Natural Anti-HIV Peptides

Could Mitochondrial DNA Quantitation Be a Surrogate Marker for Drug Mitochondrial Toxicity?

FDA Issues Labeling Changes for Efavirenz

Integrase Inhibitors Suppress SHIV Replication in Rhesus Macaques

Light on the Obscure Field of Non-occupational HIV Post-exposure Prophylaxis

HIV Guidelines